Sanj K. Patel, CHAIRMAN & CEO at Kiniksa Pharmaceuticals International, plc (KNSA), sold 12,109 shares at $50.01 ($600K) on 2026-04-06, disclosed to the SEC on 2026-04-08.
Scheduled sale ($600k) by CHAIRMAN & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.01 | 7,278 | $364K | 60.6% |
| 2 | $48.94 | 4,831 | $236K | 39.4% |
| Total | $49.58 avg | 12,109 | $600K | 100% |
| Filing → |
| KNSA | SELL | 2025-10-22 | $20.0M | — | Filing → |
| KNSA | SELL | 2025-05-28 | $4.6M | — | Filing → |
| KNSA | SELL | 2025-05-22 | $127K | — | Filing → |